Your Trusted Brand for Over 35 Years

Life Extension Magazine

<< Back to June 2014

The 2013 SENS Foundation Conference

June 2014

By Ben Best

Cryogenic Preservation Of Transplantable Organs

Stephen Van Sickle (Chief Scientific Officer, Arigos Biomedical, Mountain View, California) is part of a company that is taking a novel approach to preserving transplantable organs. Transplantable hearts, kidneys, pancreases, and livers can be preserved for longer times prior to transplant by replacing blood in the blood vessels with cold gas rather than a cold fluid.65 The cold gas, like the cold fluid, has traditionally been above freezing temperature.

Instead of using a gas with high oxygen content above freezing temperature, Van Sickle’s company has been using helium gas that can cool down to cryogenic temperatures (below -130° Celsius). Although hypothermic cooling can maintain transplantable organs for hours above freezing temperature, cooling to cryogenic temperatures has the potential to preserve organs much longer.

Despite the shortage of transplantable kidneys, nearly a fifth of such kidneys are discarded because at the time of harvest a suitable patient or clinic is not available. Longer preservation times would prevent this waste. Substituting blood with a vitrification (glass-forming) solution that prevents ice formation has allowed for cooling of a rabbit kidney to -130°C with viability restored upon rewarming. However, vitrification and successful revival with the transplant of organs larger than a rabbit kidney has not yet occurred.66

Cooling an organ internally with cold helium gas provides another option. Van Sickle has been able to cool a pig kidney (which is comparable in size to a human kidney) down to -180°C without fracture. Van Sickle believes that perfusing organs with helium gas at higher pressures (20 atmospheres) could allow for cooling rates that are 100 times faster than is possible with current methods. Hopefully, the cooling would be fast enough to prevent damaging the tissues by dehydration from the helium gas. Rewarming the organs with helium gas requires combining the warm helium gas with electrically-induced heat (radio frequency electromagnetic currents).

Punting On The Cam

There were more than 70 speakers at the SENS6 conference, so the above sampling only gives a taste of the full program. On the final day of SENS6, the participants had an opportunity to go “punting on the Cam.” This is not a form of football. Punting means using a large pole to propel a boat on the Cambridge River. Many scientific discussions about the conference happen on the boats.

Summary

The SENS (Strategies for Engineered Negligible Senescence) Foundation conference in Cambridge, England, attracts some of the world’s top scientists devoted to human rejuvenation—and this year was no exception.

Dr. George Church, Professor of Genetics at Harvard Medical School, identified several genes he believes contribute to health and longevity, including one that delays Alzheimer’s disease by 10 years. He is hopeful gene therapy can be used to make these genes available to everyone.

Dr. Luigi Fontana of the Longevity Research Program in Missouri is investigating how calorie restrictions promote a longer life and improve health, while Dr. Sam Parnia (Professor of Medicine and Director of CPR Research at State University of New York) discussed how CPR methods are all too often not done properly in hospitals and how lives can be saved if they were.

Tissue regeneration was Dr. Malcolm Maden’s topic. He is studying the Mexican salamander, which has the ability to regenerate every organ in its body. Dr. Maden has shown that applying retinoic acid to the spinal cord of rodents causes nerve fibers to regrow. He hopes studying the regeneration of the salamanders will lead to tissue regeneration in humans.

If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.

References

  1. Shkolnikov VM, Jdanov DA, Andreev EM, Vaupel JW. Steep increase in best-practice cohort life expectancy. Popul Dev Rev. 2011;37(3):419-34.
  2. Pennisi E. The CRISPR craze. Science. 2013 Aug 23;341(6148):833-6.
  3. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013 Sep;31(9):833-8.
  4. Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat Methods. 2013 Oct;10(10):957-63.
  5. Huh D, Kim HJ, Fraser JP, Shea DE, Khan M, Bahinski A, Hamilton GA, Ingber DE. Microfabrication of human organs-on-chips. Nat Protoc. 2013 Nov;8(11):2135-57.
  6. Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science. 2010 Apr 16;328(5976):321-6.
  7. Walford RL, Harris SB, Gunion MW. The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11533-7.
  8. Verdery RB, Walford RL. Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch Intern Med. 1998 Apr 27;158(8):900-6.
  9. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6659-63.
  10. Meyer TE, Kovács SJ, Ehsani AA, Klein S, Holloszy JO, Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol. 2006 Jan 17;47(2):398-402.
  11. Fontana L, Klein S, Holloszy JO. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr). 2010 Mar;32(1):97-108.
  12. Thayer JF, Ahs F, Fredrikson M, Sollers JJ 3rd, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev. 2012 Feb;36(2):747-56.
  13. Stein PK, Soare A, Meyer TE, Cangemi R, Holloszy JO, Fontana L. Caloric restriction may reverse age-related autonomic decline in humans. Aging Cell. 2012 Aug;11(4):644-50.
  14. Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. Cell culture. Progenitor cells from human brain after death. Nature. 2001 May 3;411(6833):42-3.
  15. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I; Resuscitation Outcomes Consortium Investigators. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008 Sep 24;300(12):1423-31.
  16. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010 Jun 2;303(21):2165-71.
  17. Parnia S, Nasir A, Ahn A, Malik H, Yang J, Zhu J, Dorazi F, Richman P. A Feasibility Study of Cerebral Oximetry During In-Hospital Mechanical and Manual Cardiopulmonary Resuscitation. Crit Care Med. 2013 Nov 15.
  18. Goldberger ZD, Chan PS, Berg RA, Kronick SL, Cooke CR, Lu M, Banerjee M, Hayward RA, Krumholz HM, Nallamothu BK; American Heart Association Get With The Guidelines—Resuscitation (formerly National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet. 2012 Oct 27;380(9852):1473-81.
  19. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21;346(8):549-56.
  20. Nichol G, Huszti E, Kim F, Fly D, Parnia S, Donnino M, Sorenson T, Callaway CW; American Heart Association Get With the Guideline-Resuscitation Investigators. Does induction of hypothermia improve outcomes after in-hospital cardiac arrest? Resuscitation. 2013 May;84(5):620-5.
  21. Eguchi G, Eguchi Y, Nakamura K, Yadav MC, Millán JL, Tsonis PA. Regenerative capacity in newts is not altered by repeated regeneration and ageing. Nat Commun.2011 Jul 12;2:384.
  22. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857354/. Accessed March 27, 2014.
  23. Kragl M, Knapp D, Nacu E, Khattak S, Maden M, Epperlein HH, Tanaka EM. Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature. 2009 Jul 2;460(7251):60-5.
  24. Maden M, Manwell LA, Ormerod BK. Proliferation zones in the axolotl brain and regeneration of the telencephalon. Neural Dev. 2013 Jan 17;8(1):1
  25. Monaghan JR, Maden M. Visualization of retinoic acid signaling in transgenic axolotls during limb development and regeneration. Dev Biol. 2012 Aug 1;368(1):63-75.
  26. Corcoran J, So PL, Barber RD, Vincent KJ, Mazarakis ND, Mitrophanous KA, Kingsman SM, Maden M. Retinoic acid receptor beta2 and neurite outgrowth in the adult mouse spinal cord in vitro. J Cell Sci. 2002 Oct 1;115(Pt 19):3779-86.
  27. Austad SN. Methusaleh’s Zoo: how nature provides us with clues for extending human health span. J Comp Pathol. 2010 Jan;142 Suppl 1:S10-21.
  28. Nagy JD, Victor EM, Cropper JH. Why don’t all whales have cancer? A novel hypothesis resolving Peto’s paradox. Integr Comp Biol. 2007 Aug;47(2):317-28.
  29. Albanes D. Height, early energy intake, and cancer. Evidence mounts for the relation of energy intake to adult malignancies. BMJ. 1998 Nov 14;317(7169):1331-2.
  30. Caulin AF, Maley CC. Peto’s Paradox: evolution’s prescription for cancer prevention. Trends Ecol Evol. 2011 Apr;26(4):175-82.
  31. Li Y, de Magalhães JP. Accelerated protein evolution analysis reveals genes and pathways associated with the evolution of mammalian longevity. Age (Dordr). 2013 Apr;35(2):301-14.
  32. Chen HY, White E. Role of autophagy in cancer prevention. Cancer Prev Res (Phila). 2011 Jul;4(7):973-83.
  33. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal. 2010 Apr;12(4):503-35.
  34. Brunk UT, Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002 Sep 1;33(5):611-9.
  35. Julien S, Schraermeyer U. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol Aging. 2012 Oct;33(10):2390-7.
  36. Zinno F, Landi F, Aureli V, Caniglia M, Pinto RM, Rana I, Balduino G, Miele MJ, Picardi A, Arcese W, Isacchi G. Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein’s thawing technique used in 40 transplantation procedures. Transfus Apher Sci. 2010 Oct;43(2):173-8.
  37. Stanevsky A, Shimoni A, Yerushalmi R, Nagler A. Double umbilical cord blood transplant: more than a cell dose? Leuk Lymphoma. 2010 Jun;51(6):975-82.
  38. Reichle A, Zaiss M, Rothe G, Schmitz G, Andreesen R. Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells. Bone Marrow Transplant. 2003 Aug;32(3):299-305.
  39. Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion. 2006 Nov;46(11):1934-42.
  40. Ludwig FC, Elashoff RM. Mortality in syngeneic rat parabionts of different chronological age. Trans N Y Acad Sci. 1972 Nov;34(7):582-7.
  41. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA.Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005 Feb 17;433(7027):760-4.
  42. Dykstra B, Olthof S, Schreuder J, Ritsema M, de Haan G. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med. 2011 Dec 19;208(13):2691-703.
  43. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011 Aug 31;477(7362):90-4.
  44. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010 Jan 19;17(1):41-52.
  45. Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. The role of SIRT1 in ocular aging. Exp Eye Res. 2013 Nov;116:17-26.
  46. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010 Nov 24;143(5):802-12.
  47. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010 Dec 1;12(6):662-7.
  48. Bell EL, Guarente L. The SirT3 divining rod points to oxidative stress. Mol Cell. 2011 Jun 10;42(5):561-8.
  49. Brown K, Xie S, Qiu X, Mohrin M, Shin J, Liu Y, Zhang D, Scadden DT, Chen D. SIRT3 reverses aging-associated degeneration. Cell Rep. 2013 Feb 21;3(2):319-27.
  50. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell. 2011 Mar 8;19(3):416-28.
  51. Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics. 2005 Feb;85(2):258-63.
  52. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones TL. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):4012-7.
  53. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005 Sep 27;112(13):2047-60.
  54. Available at: http://www.brighamandwomens.org/Departments_and_Services/medicine/services/cvcenter/Amyloidosis/patients.aspx . Accessed March 27, 2014.
  55. Bourgault S, Solomon JP, Reixach N, Kelly JW. Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion. Biochemistry. 2011 Feb 15;50(6):1001-15.
  56. Available at: http://www.circ.ahajournals.org/content/124/9/1079.long. Accessed March 27, 2014.
  57. Falk RH. Cardiac amyloidosis: a treatable disease, often overlooked. Circulation. 2011 Aug 30;124(9):1079-85.
  58. Coles LS, Young RD. Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension. Prev Med. 2012 May;54 Suppl:S9-11.
  59. O’Nuallain B, Allen A, Ataman D, Weiss DT, Solomon A, Wall JS. Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope. Biochemistry. 2007 Nov 13;46(45):13049-58.
  60. Shay JW, Reddel RR, Wright WE. Cancer. Cancer and telomeres--an ALTernative to telomerase. Science. 2012 Jun 15;336(6087):1388-90.
  61. Osterwald S, Wörz S, Reymann J, Sieckmann F, Rohr K, Erfle H, Rippe K. A three-dimensional colocalization RNA interference screening platform to elucidate the alternative lengthening of telomeres pathway. Biotechnol J. 2012 Jan;7(1):103-16.
  62. Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, Reddel RR. DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol. 2009 Dec;27(12):1181-5.
  63. Conomos D, Stutz MD, Hills M, Neumann AA, Bryan TM, Reddel RR, Pickett HA.Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. J Cell Biol. 2012 Dec 10;199(6):893-906.
  64. Lafferty-Whyte K, Cairney CJ, Will MB, Serakinci N, Daidone MG, Zaffaroni N, Bilsland A, Keith WN. A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene. 2009 Oct 29;28(43):3765-74.
  65. Suszynski TM, Rizzari MD, Scott WE 3rd, Tempelman LA, Taylor MJ, Papas KK. Persufflation (or gaseous oxygen perfusion) as a method of organ preservation. Cryobiology. 2012 Jun;64(3):125-43.
  66. Fahy GM, Wowk B, Pagotan R, Chang A, Phan J, Thomson B, Phan L. Physical and biological aspects of renal vitrification. Organogenesis. 2009 Jul;5(3):167-75.